Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 3—March 2011

Research

Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007

Christof J. MajoorComments to Author , Cecile Magis-Escurra, Jakko van Ingen, Martin J. Boeree, and Dick van Soolingen
Author affiliations: Author affiliations: Academic Medical Center, Amsterdam, the Netherlands (C.J. Majoor); Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (C. Magis-Escurra, J. van Ingen, M.J. Boeree, D. van Soolingen); National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (J. van Ingen, D. van Soolingen)

Main Article

Table 2

Treatment results according to age, sex, and localization of Mycobacterium bovis disease in Dutch and foreign-born case-patients, as recorded in the National Tuberculosis Registry, the Netherlands, 1993–2007*

Variable No. (%) Dutch patients, n = 138

No. (%) foreign-born patients, n = 93
Treatment completed Cause of death
Other† Treatment completed Cause of death
Other†
TB-related Non–TB-related TB-related Non–TB-related
Total
85 (61.6)
10 (7.2)
28 (20.3)
15 (10.9)

66 (71.0)
2 (2.1)
6 (6.5)
19 (20.4)
Age, y
0–60 25 1 3 6 59 2 3 16
>60
60
9
25
9

7
0
3
3
Sex
M 33 3 18 2 35 0 3 11
F
52
7
10
13

31
2
3
8
Localization
Pulmonary 26 2 9 3 21 0 2 5
Extrapulmonary 52 5 11 10 44 0 3 11
Pulmonary and
extrapulmonary 7 3 8 2 1 2 1 3

*TB, tuberculosis.
†Treatment not completed or treatment continued elsewhere.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO